Cascallo M - Search Results

1

Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors.

Nokisalmi P, Pesonen S, Escutenaire S, Särkioja M, Raki M, Cerullo V, Laasonen L, Alemany R, Rojas J, Cascallo M, Guse K, Rajecki M, Kangasniemi L, Haavisto E, Karioja-Kallio A, Hannuksela P, Oksanen M, Kanerva A, Joensuu T, Ahtiainen L, Hemminki A. Nokisalmi P, et al. Among authors: cascallo m. Clin Cancer Res. 2010 Jun 1;16(11):3035-43. doi: 10.1158/1078-0432.CCR-09-3167. Epub 2010 May 25. Clin Cancer Res. 2010. PMID: 20501623 Clinical Trial.

2

Adenovirus-mediated gene transfer to tumor cells.

Cascalló M, Alemany R. Cascalló M, et al. Methods Mol Biol. 2004;246:121-38. doi: 10.1385/1-59259-650-9:121. Methods Mol Biol. 2004. PMID: 14970588

3

Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.

Cascallo M, Alonso MM, Rojas JJ, Perez-Gimenez A, Fueyo J, Alemany R. Cascallo M, et al. Mol Ther. 2007 Sep;15(9):1607-15. doi: 10.1038/sj.mt.6300239. Epub 2007 Jun 19. Mol Ther. 2007. PMID: 17579575 Free article.

4

ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.

Alonso MM, Cascallo M, Gomez-Manzano C, Jiang H, Bekele BN, Perez-Gimenez A, Lang FF, Piao Y, Alemany R, Fueyo J. Alonso MM, et al. Among authors: cascallo m. Cancer Res. 2007 Sep 1;67(17):8255-63. doi: 10.1158/0008-5472.CAN-06-4675. Cancer Res. 2007. PMID: 17804740

5

Oncolytic viruses from the perspective of the immune system.

Alemany R, Cascallo M. Alemany R, et al. Among authors: cascallo m. Future Microbiol. 2009 Jun;4(5):527-36. doi: 10.2217/fmb.09.28. Future Microbiol. 2009. PMID: 19492964

6

Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression.

Rodríguez-García A, Giménez-Alejandre M, Rojas JJ, Moreno R, Bazan-Peregrino M, Cascalló M, Alemany R. Rodríguez-García A, et al. Among authors: cascallo m. Clin Cancer Res. 2015 Mar 15;21(6):1406-18. doi: 10.1158/1078-0432.CCR-14-2213. Epub 2014 Nov 12. Clin Cancer Res. 2015. PMID: 25391696

7

The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma.

Martínez-Vélez N, Xipell E, Vera B, Acanda de la Rocha A, Zalacain M, Marrodán L, Gonzalez-Huarriz M, Toledo G, Cascallo M, Alemany R, Patiño A, Alonso MM. Martínez-Vélez N, et al. Among authors: cascallo m. Clin Cancer Res. 2016 May 1;22(9):2217-25. doi: 10.1158/1078-0432.CCR-15-1899. Epub 2015 Nov 24. Clin Cancer Res. 2016. PMID: 26603261

8

Ras-dependent oncolysis with an adenovirus VAI mutant.

Cascalló M, Capellà G, Mazo A, Alemany R. Cascalló M, et al. Cancer Res. 2003 Sep 1;63(17):5544-50. Cancer Res. 2003. PMID: 14500393

9

Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.

Gros A, Puig C, Guedan S, Rojas JJ, Alemany R, Cascallo M. Gros A, et al. Among authors: cascallo m. Mol Ther. 2010 May;18(5):903-11. doi: 10.1038/mt.2010.22. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179683 Free PMC article.

10

Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth.

Guedan S, Rojas JJ, Gros A, Mercade E, Cascallo M, Alemany R. Guedan S, et al. Among authors: cascallo m. Mol Ther. 2010 Jul;18(7):1275-83. doi: 10.1038/mt.2010.79. Epub 2010 May 4. Mol Ther. 2010. PMID: 20442708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters